Bora Pharmaceuticals Co. Ltd (BORAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 113,447 | 93,907 | 69,522 | 50,935 | 154,100 |
| Depreciation Amortization | 34,879 | 27,370 | 18,118 | 8,913 | 31,919 |
| Accounts receivable | 44,566 | 70,094 | 82,321 | 24,118 | -53,092 |
| Accounts payable and accrued liabilities | 4,503 | 833 | 2,261 | 1,802 | -20,635 |
| Other Working Capital | 70,220 | 59,631 | 70,687 | 45,361 | -89,044 |
| Other Operating Activity | -123,049 | -142,467 | -154,996 | -90,241 | 7,256 |
| Operating Cash Flow | $144,565 | $109,367 | $87,912 | $40,887 | $30,503 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -35,057 | -36,454 | 813 | -800 | 7,808 |
| PPE Investments | -21,268 | -16,350 | -9,498 | -7,353 | -13,238 |
| Net Acquisitions | -19,909 | -19,787 | -15,722 | N/A | -319,861 |
| Purchase Sale Intangibles | -1,412 | -236 | -180 | 112 | -4,943 |
| Other Investing Activity | -32,253 | -32,342 | -35,568 | -31,268 | -6,869 |
| Investing Cash Flow | $-108,487 | $-104,934 | $-59,976 | $-39,421 | $-332,160 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 43,971 | 49,925 | -21,288 | -17,726 | 56,714 |
| Debt Issued | 14,766 | 12,692 | N/A | N/A | 467,138 |
| Debt Repayment | -42,120 | -29,582 | -16,934 | -7,039 | -87,244 |
| Common Stock Repurchased | -3,206 | -791 | -770 | N/A | -12,102 |
| Other Financing Activity | -57,610 | -58,032 | -5,526 | -1,615 | -49,111 |
| Financing Cash Flow | $-44,199 | $-25,787 | $-44,518 | $-26,380 | $375,396 |
| Exchange Rate Effect | -16,029 | -26,080 | -32,802 | 3,526 | 12,591 |
| Beginning Cash Position | 187,117 | 194,695 | 189,449 | 177,208 | 94,957 |
| End Cash Position | 162,968 | 147,262 | 140,064 | 155,819 | 181,288 |
| Net Cash Flow | $-24,149 | $-47,433 | $-49,385 | $-21,388 | $86,331 |
| Free Cash Flow | |||||
| Operating Cash Flow | 144,565 | 109,367 | 87,912 | 40,887 | 30,503 |
| Capital Expenditure | -21,464 | -16,563 | -9,505 | -5,156 | -13,630 |
| Free Cash Flow | 123,101 | 92,805 | 78,407 | 35,731 | 16,874 |